WHO today launched a global initiative to reduce severe, avoidable medication-associated harm in all countries by 50% over the next 5 years. The Global Patient Safety Challenge on Medication Safety aims to address the weaknesses in health systems that lead to medication errors and the severe harm that results. It lays out ways to improve
All news about your medicines, safety measures, side effects and what works well for you
The U.S. Food and Drug Administration today granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC), including those who have not received prior chemotherapy. This is the first FDA-approved treatment for metastatic MCC, a rare, aggressive form of skin cancer.
The U.S. Food and Drug Administration has approved Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Siliq which was approved last Wednesday, is administered as an injection. Siliq is intended for patients who are candidates for systemic therapy (treatment using substances that travel through the bloodstream, after being taken by mouth or injected) or
Novartis has announced the singing of a Memorandum of Understanding (MOU) between the Government of Rwanda to offer affordable medicines for the treatment of Non Communicable Diseases under its Novartis Access initiative. Rwanda therefore becomes the third after Kenya and Ethiopia, and is expected to take delivery of the Novartis Access product in early 2017.
A new study has found that neither gay men nor heterosexual people with HIV transmit the virus to their partner, provided they are on suppressive antiretroviral treatment. The PARTNER study, which is the world’s largest study of people with HIV who have had condomless sex with their HIV negative partners, was conducted by investigators from
Former world number one tennis player,Maria Sharapova, has failed a drug test for Meldonium on January 26, 2016. Meldonium (also known as Mildronate) is manufactured in Latvia, at the Institute of Organic Synthesis and used in the treatment of certain heart conditions. It works by dilating blood vessels and increasing blood flow, which in turn improves